These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 18940307

  • 1. Angiotensin receptor blockers and cardiovascular protection: are we ONTARGET?
    Ram CV, Deedwania PC.
    Am J Cardiol; 2008 Nov 01; 102(9):1281-3. PubMed ID: 18940307
    [No Abstract] [Full Text] [Related]

  • 2. Angiotensin receptor blockers: novel role in high-risk patients.
    Javed U, Deedwania PC.
    Cardiol Clin; 2008 Nov 01; 26(4):507-26. PubMed ID: 18929228
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin receptor blockers: current status and future prospects.
    Kumar S, Ram CV.
    Indian Heart J; 2007 Nov 01; 59(6):443-53. PubMed ID: 19151457
    [No Abstract] [Full Text] [Related]

  • 4. [Debate concerning the optimal blockage of the renin-angiotensin system].
    Choukroun G.
    Nephrol Ther; 2010 Jan 01; 6 Spec No 1():H1-9. PubMed ID: 20129454
    [No Abstract] [Full Text] [Related]

  • 5. Introduction: Reducing cardiovascular risk: ONTARGET--a new standard in cardiovascular protection.
    Mancia G, Unger T, Zanchetti A.
    J Hypertens Suppl; 2009 Jul 01; 27(5):S1. PubMed ID: 19587549
    [No Abstract] [Full Text] [Related]

  • 6. New opportunities in cardiovascular patient management: a survey of clinical data on the combination of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Weber MA.
    Am J Cardiol; 2007 Aug 06; 100(3A):45J-52J. PubMed ID: 17666198
    [Abstract] [Full Text] [Related]

  • 7. [Renin-angiotensin system modulation: instructions for use].
    Bellis A, Rozza F, Crispo S, Trimarco B.
    G Ital Cardiol (Rome); 2008 Feb 06; 9(2):79-89. PubMed ID: 18383770
    [Abstract] [Full Text] [Related]

  • 8. What is the role of angiotensin-receptor blockade in cardiovascular protection?
    Cohn JN.
    Am Heart J; 2006 Nov 06; 152(5):859.e1-8. PubMed ID: 17070145
    [Abstract] [Full Text] [Related]

  • 9. Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.
    Balamuthusamy S, Srinivasan L, Verma M, Adigopula S, Jalandhara N, Hathiwala S, Smith E.
    Am Heart J; 2008 May 06; 155(5):791-805. PubMed ID: 18440325
    [Abstract] [Full Text] [Related]

  • 10. A vaccine for hypertension.
    Ménard J.
    J Hypertens; 2007 Jan 06; 25(1):41-6. PubMed ID: 17143170
    [No Abstract] [Full Text] [Related]

  • 11. Antihypertensive strategy based on angiotensin II receptor blockers: a new gateway to reduce risk in hypertension.
    Tocci G, Sciarretta S, Facciolo C, Volpe M.
    Expert Rev Cardiovasc Ther; 2007 Jul 06; 5(4):767-76. PubMed ID: 17605654
    [Abstract] [Full Text] [Related]

  • 12. Renin-angiotensin system modulation for treatment and prevention of cardiovascular diseases: toward an optimal therapeutic strategy.
    Giles TD.
    Rev Cardiovasc Med; 2007 Jul 06; 8 Suppl 2():S14-21. PubMed ID: 17401312
    [Abstract] [Full Text] [Related]

  • 13. Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in preventive cardiology: which drug to use and what to expect in light of the ONTARGET trial.
    Cairns JA.
    Pol Arch Med Wewn; 2008 Jun 06; 118(6):335-8. PubMed ID: 18619187
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of the renin-angiotensin system in cardiovascular protection: Is it important to watch your C'ARB' intake?
    Strauss MH, Verma S.
    Can J Cardiol; 2005 May 15; 21(7):577-80. PubMed ID: 15940355
    [No Abstract] [Full Text] [Related]

  • 15. Blocking the renin-angiotensin system: dual- versus mono-therapy.
    Ravandi A, Teo KK.
    Expert Rev Cardiovasc Ther; 2009 Jun 15; 7(6):667-74. PubMed ID: 19505282
    [Abstract] [Full Text] [Related]

  • 16. Role of angiotensin receptor blockers in the prevention and treatment of arrhythmias.
    Garg S, Narula J, Marelli C, Cesario D.
    Am J Cardiol; 2006 Mar 15; 97(6):921-5. PubMed ID: 16516603
    [Abstract] [Full Text] [Related]

  • 17. Dual renin-angiotensin system blockade and kidney disease.
    Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Pfeffer MA.
    J Am Coll Cardiol; 2009 Jul 14; 54(3):278-9; author reply 279-80. PubMed ID: 19589445
    [No Abstract] [Full Text] [Related]

  • 18. RAAS inhibition/blockade in patients with cardiovascular disease: implications of recent large-scale randomised trials for clinical practice.
    Pitt B.
    Heart; 2009 Aug 14; 95(15):1205-8. PubMed ID: 19401281
    [No Abstract] [Full Text] [Related]

  • 19. Moving beyond angiotensin II to also target aldosterone?
    Little WC, Kirkman PM.
    J Am Coll Cardiol; 2009 Aug 04; 54(6):513-4. PubMed ID: 19643311
    [No Abstract] [Full Text] [Related]

  • 20. Defining the role of renin/angiotensin-targeted antihypertensive therapy in decreasing cardiovascular risk: evidence, guideline evolution, and questions to be resolved.
    Probstfield J.
    J Fam Pract; 2009 Jun 04; 58(6 Suppl):S1-8. PubMed ID: 19508849
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.